Alfa Financial Software Holdings PLC (ALFA)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 176.20 |
|---|---|
| 52-week range | 140.40 – 240.00 |
| Return, 1 month / 3 months | +11.5% / +7.2% |
| Return, 1 year / 3 years | −21.6% / +24.6% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 31.1% |
| Worst drawdown (1 year) | -38.6% |
| Average daily value traded | 126.76M GBX |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alfa Financial Software Holdings develops and supports Alfa Systems, a software platform used by companies in asset finance, automotive finance and equipment leasing. Its customers include banks, captive finance arms of manufacturers and independent leasing businesses, who use the software to manage contracts, lending and related operations. The company is based in London, United Kingdom, and provides implementation, integration and ongoing support services alongside its core product.
Alfa Financial Software Holdings PLC trades under the code ALFA on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alfa Financial Software Holdings PLC (ALFA) trades on the London Exchange in UK. It last closed at GBX 176.20 on 22 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 1,754 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.6% and over the last three months it rose 7.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 6.7% | ||
| From 52-week high | -24.1% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.2% | ||
| 6-month return | 12.2% | ||
| 12-month return, skipping the last month | -29.7% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.6% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 126.76M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +7.6% |
|---|---|
| 1 month | +11.5% |
| 3 months | +7.2% |
| 6 months | +12.2% |
| 1 year | −21.6% |
| 3 years | +24.6% |
| 5 years | +23.4% |
Signals
| 50-day / 200-day average | 161.34 / 165.21 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.41 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 May 2026 | GBP 0.0150 |
| 30 Apr 2026 | GBP 0.0310 |
| 25 Sep 2025 | GBP 0.0500 |
| 29 May 2025 | GBP 0.0140 |
| 1 May 2025 | GBP 0.0240 |
| 26 Sep 2024 | GBP 0.0420 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.